Press release
Cancer Biomarkers Market 2020 - 2027 Global Size, Share, Industry Key Players like Abbott Laboratories, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, Exact Sciences
Cancer Biomarkers Market
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/1443
Surge in number of patients suffering from various types of cancers such as prostate, breast, and lung cancer, rise in number of clinical trials, and high accuracy & reliability drive the growth of the global cancer biomarkers market. However, high cost associated with drug development and fatal effects of cancer drug therapy restrain the market growth. Furthermore, technological advancements in cancer therapy and focus on advanced treatment protocols are expected to create new growth opportunities for the market players.
Covid-19 scenario:
Several major market players have halted the manufacturing of cancer biomarker diagnostic tools amidst the lockdown enforeced by governments during the Covid-19 pandemic.
The demand for cancer biomarkers is expected to surge during the Covid-19 pandemic to diagnose conditions by identifying early stage cancers (diagnostic) and forecast how aggressive a condition can proceed in order to decide the course of treatment (prognostic). The medical diagnostics industry has not suffered the severe impacts.
Request for Detailed COVID-19 Impact Sample Report at: https://www.alliedmarketresearch.com/request-for-customization/1443?reqfor=covid
The genetic biomarkers segment to dominate during the estimated period-
Based on biomolecule, the genetic biomarkers segment contributed to nearly half of the global cancer biomarkers market revenue in 2019, and is anticipated to lead the trail till 2027. This is due to its accuracy and precision while detecting cancer and monitoring the effectiveness of the treatment. Simultaneously, the glycol-biomarkers segment would portray the fastest CAGR of 12.5% by 2027. Increase in awareness about the roles of glycosylation and other post translational modifications in cancer biology fuels the segment growth.
The omic technologies segment to maintain the lion's share by 2027-
Based on profiling technologies, the omic technologies segment accounted for more than half of the global cancer biomarkers market share in 2019, and is expected to rule the roost by the end of 2027. This is attributed to factors such as rise in use of personalized medicines for cancer treatment and growth in healthcare expenditure among people. The immunoassays segment, on the other hand, would register the fastest CAGR of 16.4% throughout the forecast period, owing to various advantages offered by immunoassays such as simultaneous analysis of multiple compounds, analysis at minute concentrations, and increased efficiency of diagnosis and treatment.
North America to dominate in terms of revenue-
Based on geography, North America held the major share, garnering more than one-third of the global cancer biomarkers market, owing to strong focus on innovation and technological advancements in healthcare & diagnostics in the region. At the same time, Asia-Pacific is expected to manifest the fastest CAGR of 15.1% from 2020 to 2027. This is due to increase in prevalence of cancer, rise in patient awareness, and increase in disposable incomes in the province.
Frontrunners in the industry-
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Bristol-Myers Squibb Company
Exact Sciences Corporation
F.Hoffmann-La Roche Ltd.
Abbott Laboratories
Qiagen N.V.
Merck KGaA
PerkinElmer, Inc.
Siemens AG
Access Full Report: https://www.alliedmarketresearch.com/cancer-biomarkers-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
About Us:
Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market 2020 - 2027 Global Size, Share, Industry Key Players like Abbott Laboratories, Bio-Rad Laboratories, Inc., Bristol-Myers Squibb Company, Exact Sciences here
News-ID: 2181807 • Views: …
More Releases from Allied Market Research
Cattle Feed Market Size worth USD 78.3 Billion Globally, by 2027 at a CAGR of 4. …
Cattle feed market size was estimated at $73.5 billion in 2019, and is expected to hit $78.3 billion by 2027, and registering with a CAGR of 4.4% from 2021 to 2027.
Replacement of traditional cattle feed with nutritionally balanced compound feed and livestock industrialization drive the growth of the global cattle feed market. On the other hand, challenges related to the gap between demand and supply of cattle feed act as…
Luxury Travel Market Size to Hit US$ 2149.7 billion by 2035 at 7.4% CAGR
According to a new report published by Allied Market Research, titled, "Luxury Travel Market," The luxury travel market size was valued at $890.8 billion in 2023, and is estimated to reach $2149.7 billion by 2035, growing at a CAGR of 7.4% from 2024 to 2035.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/1662
Luxury travel refers to travel experiences that offer exceptional comfort, exclusivity, and personalized services, typically catering to…
Hotel Toiletries Market is likely to expand US$ 50.5 billion at 10.8% CAGR by 20 …
The hotel toiletries market was valued at $17.9 billion in 2021, and is estimated to reach $50.5 billion by 2031, growing at a CAGR of 10.8% from 2022 to 2031.
Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/75060
There is a greater demand for hotel toiletries with the growth of the tourism industry and the rise in international travel. Improved transportation, economic growth, globalization, technology advancements, and other initiatives have…
FMCG Industry Set to Achieve a Valuation of US$ 18,939.4 billion, Riding on a 5. …
According to a new report published by Allied Market Research, titled, "FMCG Market by Product Type, Production Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2022-2031," the global FMCG market size is expected to reach $18,939.4 billion by 2031 at a CAGR of 5.1% from 2022 to 2031.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/5148
Fast-moving consumer goods (FMCG) is the largest combination of consumer goods…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
